News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News ACC 2021 High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE Michael O'Riordan May 15, 2021
News Daily News Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS Todd Neale May 14, 2021
News Conference News SCAI 2021 Chinese Registry Supports Prolonged DAPT Following PCI for ACS Yael L. Maxwell May 03, 2021
News Daily News Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA Yael L. Maxwell April 29, 2021
News Opinion Off Script Yes, You Believe in Transplantation: But Could You Save My Life? Roxanne Watson April 22, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI Yael L. Maxwell April 05, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News Complicated Pregnancies and CVD Risk: Cardiologists Can Be Part of Solution Caitlin E. Cox March 30, 2021
News Daily News Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future L.A. McKeown March 17, 2021
News Conference News ISC 2021 Study Bolsters Link Between Silent MI and Ischemic Stroke Todd Neale March 15, 2021
News Daily News EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case Yael L. Maxwell March 03, 2021
News Daily News Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy Michael O'Riordan February 26, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021